Yang Rujing, Liu Xinyu, Zhao Zhexuan, Zhao Yan, Jin Xiaoqing
Emergency Center, Hubei Clinical Research Center for Emergency and Resuscitation, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, Hubei, 430071, China.
The Second Clinical School, Wuhan University, Wuhan, Hubei, 430071, China.
BMC Public Health. 2025 Feb 20;25(1):706. doi: 10.1186/s12889-025-21928-9.
Neurological diseases are a significant contributor to premature mortality and temporary or long-term disability among survivors. Asia serves as an essential region for assessing the shifting burden of these disorders. This study aims to calculate and evaluate the changes in burden of neurological diseases across Asia.
The Global Burden of Disease database provided data on deaths, disability-adjusted life-years (DALYs), incidence, and prevalence from 1990 to 2021 across Asian subregions and countries. Twelve common neurological diseases were analyzed. Estimated Annual Percent Change were calculated to reveal trends in all the metrics. The Nordpred age-period-cohort model was employed to project the neurological disease burden.
In 2021, the leading neurological disorders in DALYs were stroke (109,144.87, 95% uncertainty intervals (UI) 95,992.89-123,089.90), headache disorders (25,713.91, 95%UI 4,693.65-54,853.47), and Alzheimer's disease and other dementias (19,156.46, 95% UI 9,137.72-41,421.18). Stroke and degenerative neurological disorder presented the most severe burden in East Asia, while headache disorders were prominent in South Asia. Between 1990 and 2021, Asia's regions showed varying reductions in age-standardized DALYs and age-standardized death rates for neurological diseases, with the steepest decline observed in high-income Asia Pacific (DALYs -2.27, 95% confidence interval (CI) -2.4 to -2.13; ASDR -3.85, 95% CI -4.02 to -3.69). Neurological disease burden was higher in males, peaking at ages 65-74. Projections to 2045 indicate a decline in DALYs for stroke, infectious neurological diseases, Parkinson's disease, and idiopathic epilepsy across most regions of Asia. In contrast, trends for other neurological diseases will vary regionally.
Neurological diseases were the primary cause of DALYs in 2021, ranking second only to cardiovascular diseases as a leading cause of death. As the aging trend in Asia's population continues to intensify, it is crucial to focus more on the prevention and management of neurological disorders.
神经系统疾病是导致过早死亡以及幸存者出现短期或长期残疾的重要因素。亚洲是评估这些疾病负担变化的关键地区。本研究旨在计算和评估亚洲地区神经系统疾病负担的变化。
全球疾病负担数据库提供了1990年至2021年期间亚洲各次区域和国家的死亡数据、伤残调整生命年(DALYs)、发病率和患病率。分析了12种常见的神经系统疾病。计算年度估计百分比变化以揭示所有指标的趋势。采用Nordpred年龄-时期-队列模型预测神经系统疾病负担。
2021年,伤残调整生命年方面主要的神经系统疾病为中风(109,144.87,95%不确定区间(UI)95,992.89 - 123,089.90)、头痛障碍(25,713.91,95% UI 4,693.65 - 54,853.47)以及阿尔茨海默病和其他痴呆症(19,156.46,95% UI 9,137.72 - 41,421.18)。中风和退行性神经系统疾病在东亚呈现出最严重的负担,而头痛障碍在南亚较为突出。1990年至2021年期间,亚洲各地区神经系统疾病的年龄标准化伤残调整生命年和年龄标准化死亡率有不同程度的下降,其中高收入亚太地区下降最为显著(伤残调整生命年 -2.27,95%置信区间(CI) -2.4至 -2.13;年龄标准化死亡率 -3.85,95% CI -4.02至 -3.69)。男性的神经系统疾病负担更高,在65 - 74岁达到峰值。到2045年的预测表明,亚洲大部分地区中风、感染性神经系统疾病、帕金森病和特发性癫痫的伤残调整生命年将下降。相比之下,其他神经系统疾病的趋势将因地区而异。
神经系统疾病是2021年伤残调整生命年的主要原因,作为主要死因仅次于心血管疾病。随着亚洲人口老龄化趋势持续加剧,更加关注神经系统疾病的预防和管理至关重要。